NCT01740804
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- Guangdong general hospital Guangzhou, Guangdong, China
Clinical trial condition
Carcinoma, Non-Small-Cell Lung
Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.
4,700 public trials
1,041 recruiting studies
Carcinoma, Non-Small-Cell Lung trial results
Completed
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
NCT00032032
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Mayo Clinic - Jacksonville Jacksonville, Florida, United States
- McFarland Clinic, PC Ames, Iowa, United States
- Mercy Capitol Hospital Des Moines, Iowa, United States
NCT01294306
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +19 more
- Locations
-
- Tower Cancer Research Foundation Beverly Hills, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT02972216
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
- Locations
-
Not specified
NCT00124280
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Nevada Cancer Institute Las Vegas, Nevada, United States
- MD Anderson Cancer Center, Department of Thoracic /Head and Neck Medical Oncology Houston, Texas, United States
Completed
BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I
NCT00876460
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- 1199.29.002 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka, Japan
- 1199.29.001 Boehringer Ingelheim Investigational Site Osaka-Sayamashi, Osaka, Japan
NCT01814553
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- 1200.167.01009 Boehringer Ingelheim Investigational Site Santa Rosa, California, United States
- 1200.167.01020 Boehringer Ingelheim Investigational Site Orlando, Florida, United States
- 1200.167.01018 Boehringer Ingelheim Investigational Site Port Saint Lucie, Florida, United States
- 1200.167.01012 Boehringer Ingelheim Investigational Site St. Petersburg, Florida, United States
Completed
Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer
NCT01839955
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Cleveland, Ohio, United States
NCT02445924
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Chest Department, Faculty of Medicine, Tanta University Tanta, Gharbia Governorate, Egypt
NCT01605916
- Conditions
- Advanced Solid Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
- Locations
-
- Research Site Fukuoka, Japan
- Research Site Kashiwa-shi, Japan
- Research Site Nagoya, Japan